Advancement in Patient Treatment Goals and Targeted Approaches in Chronic Lymphocytic Leukemia

This webinar was recorded on October 5, 2023
Sponsored by Abbvie

This webinar is intended for US Formulary Decision Makers only.

This webinar explores the evolution of the treatment landscape, goals of treatment, and managed care considerations in Chronic Lymphocytic Leukemia (CLL) and provides an update on the new clinical data and real-world evidence for a targeted therapy in the treatment of patients living with CLL.

Learning Objectives:

• Review the CLL disease state, evolving treatment goals, and remaining unmet needs
• Outline patient, disease, clinical and health-economic considerations for managed care in the treatment of CLL
• Describe the efficacy and safety of a targeted therapy, fixed treatment duration regimen in CLL
• Provide an overview of the real-world experience of a fixed treatment duration regimen in CLL

Speaker:

Bita Fakhri, MD, MPH
Assistant Professor of Medicine (Hematology)
Stanford Cancer Institute
Stanford HealthCare

This webinar is sponsored, developed, and presented by the sponsor. The content of this Science & Innovation Webinar and opinions expressed by the presenter are those of the sponsor or presenter and not of AMCP.

Sponsored by:

BCL2-US-00082-MC
September 2023